Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. - Wikidata - wikimedia - TriplyDB

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.

http://www.wikidata.org/entity/Q35083980

about

IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance Regulation of hepatic innate immunity by hepatitis C virus Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.Genetic variations in IL28B and allergic disease in children.Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection Host Genetic Factors and Dendritic Cell Responses Associated with the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals.Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013.Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction Privacy-preserving genomic testing in the clinic: a model using HIV treatment.Individualization of chronic hepatitis C treatment according to the host characteristics.IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.Host genomics and HCV treatment response.Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C.Pharmacogenomics: what is next?Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals With Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay.The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.Innate immunity: a new chapter for hepatitis C.Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.

P2860

Q22121973-1A00E2D4-A371-4F39-945D-935FBC1E2637 Q26824743-698CFB56-A690-46C2-AC75-E7A3D1A0D957 Q27014831-96E8F161-D687-4F0A-AB75-6D0E8E5C139D Q28478435-58CEF7E2-5FD1-4E93-9DE0-F4953C098235 Q31066011-9CB47A8B-DA30-476A-8DE4-07A35F1D02FA Q33786026-225622FD-6DBE-4901-A1BE-69267871810C Q34147621-DF5DCA6A-E055-46A6-92DB-435228DDF12A Q34157284-D9875550-30F7-4603-95F6-FECF09CBD498 Q34281428-5A78C071-2E6D-48E7-A3A6-F42472418E27 Q34350873-C2541A24-4B3F-47CA-BE05-B384FDCE20DB Q34417123-5C0F7A29-11F9-4EE2-B8FE-542A4FFF48C0 Q34433087-F5EFB03F-F5E5-4081-8F7A-F8B3A85F8B64 Q34923937-C4AB808E-0592-46DE-AD61-C5070A83103B Q35095654-0AB40891-BE3F-4AEF-81B3-7D5DD959C754 Q35350883-76DF7203-504C-47AE-85C4-81BAA209CABD Q35381792-571000DB-D551-42FB-8176-371649C36C60 Q35628314-84C4592D-38CE-40B9-A259-34D3EEE209F1 Q35887966-D623FE0E-08FA-4765-B7EB-D909A4441A6A Q36907926-C95B601C-B855-439A-8A9E-5A64BD51F203 Q37176937-6445CAE7-21C8-4F62-981B-9A114A21C0A0 Q37654502-5938F080-F2C2-4755-B857-E6463115B576 Q37921307-0DE95B58-6759-456E-8284-CFCEB4E960F0 Q37932036-F5918CD1-3D02-4AFB-8693-DE86123A6070 Q37962692-40877CD5-3DAA-46C9-9EFF-77588CCEB855 Q37978619-28986FD7-3A17-4787-BB5E-DBBC11EB8F1D Q38859455-53D94002-C522-42D2-A4CB-04AA94FB0731 Q39117300-565AEBAD-F593-47F9-86C9-426B1777C109 Q39189699-1E00998B-0B10-432F-B66D-727A7235CC96 Q40705557-EC8911A3-1629-431B-96A5-780D6E8320F8 Q41216716-3A9DF3AB-1B3B-4248-832C-36AB177F6257 Q42261289-859AFC5D-2239-4B1F-994E-AE9DA862AE20 Q42406719-72094B00-10F4-4DAF-985D-F6B18D5D3235 Q42980402-6C0A6952-356E-4028-A001-757D98CDA836 Q45360519-ABAE38F1-CDFB-4098-B2F3-FCB495B6E937 Q50552789-DB4A0990-770A-4AB2-9F63-2CF8442A65BF

P2860

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.

http://www.wikidata.org/entity/Q35083980

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Estimating the net contributio ...... s hepatitis C virus clearance.

@ast

Estimating the net contributio ...... s hepatitis C virus clearance.

@en

type

label

Estimating the net contributio ...... s hepatitis C virus clearance.

@ast

Estimating the net contributio ...... s hepatitis C virus clearance.

@en

prefLabel

Estimating the net contributio ...... s hepatitis C virus clearance.

@ast

Estimating the net contributio ...... s hepatitis C virus clearance.

@en

P1433

Q35083980-500AC1CC-25EF-404F-989C-FA558E9496AA

P1476

Q35083980-A2DD6903-1C01-418D-BA14-FC4D077DDE73

P2093

Q35083980-2C6554F4-DCD9-4459-90D8-55F550EDB749

Q35083980-5EB4E0ED-AFA5-4FFA-8745-133758E9F441

Q35083980-78189C3E-98F8-4972-B9B9-EA73618FDD80

Q35083980-8365D944-DD4B-4C3F-B648-A65929309097

Q35083980-9AD673FB-818F-4109-B4F7-8E5D621CF273

Q35083980-CFD4804F-FB04-4406-A4D3-ABD6C3CE4077

Q35083980-F78757F7-82BA-41EF-B181-80A4541B2EAD

Q35083980-FE12DC1D-7602-440D-B448-8D810254CD2D

P2860

Q35083980-12E2AB9F-5840-492E-9BC0-AEC5E872B66D

Q35083980-34282D09-E8ED-4475-B04F-A0C8E7397518

Q35083980-35BCDC7D-7C16-488A-8D0E-D997EC2E94D4

Q35083980-4B1CE348-DF7A-4B0E-A082-7B7A5B83AFDC

Q35083980-5EE1D68F-FB38-4C75-A9A5-0C0CD7AC4245

Q35083980-67F705FC-66C0-4896-9C3C-FDC0A08C8C40

Q35083980-7A517546-A31D-4776-84A5-62146AC0D70C

Q35083980-85D044A1-2015-4D0D-850F-60913DC67EF1

Q35083980-903C9AAA-BB5F-4E68-A567-C04666D6CFB1

Q35083980-9D5E65B8-987D-4281-B978-BA9C384CA090

P304

Q35083980-D9430380-4A1D-485B-92D2-975C8FDB1439

P31

Q35083980-5A35D0CB-815D-4FEE-AE5B-1E50AE04077C

P356

Q35083980-622B4E6D-3955-4464-A19A-AC0C776FF4AD

P407

Q35083980-9947B0ED-BB59-4387-A5F9-A2C857FF2581

P433

Q35083980-BCBD752C-F74A-4720-9057-40CCC51A05CE

P478

Q35083980-BBDB1E91-6F32-449F-8552-6A1513908E41

P50

Q35083980-34E6504D-0527-4142-A237-32D8EAF3CC6A

Q35083980-5B1589BA-6D8A-45AC-B752-4A812F748812

Q35083980-63E6AA42-9D7A-4305-9FC8-1C7030EC0DCE

Q35083980-754459C0-7D0C-43C9-AA8A-FDFD7C17783D

Q35083980-7656A288-29DB-4455-B68C-84193D63DFBD

Q35083980-76C2C27E-7FAB-4234-8DB3-669367EC3E39

Q35083980-7D7DE635-19EC-4CF6-AF03-B3E8CA7C6013

Q35083980-82CB8AAD-C310-49BB-8B4B-3DC94118C0DB

Q35083980-93798E85-838E-432D-B428-401D289CD231

Q35083980-B5B641B5-AA19-4905-BF20-C9DBA6B7D245

P577

Q35083980-EA8AD106-BB3D-418A-9F1A-81788AB037ED

P5875

Q35083980-4DFF56EE-FFA0-4135-9C35-92D53DD81F8A

P698

Q35083980-E11D5E78-7936-484A-89E8-25CA548C5190

P932

Q35083980-5538CE41-1D09-43F6-BFB0-7C02566C835E

P356

P1433

P1476

Estimating the net contributio ...... s hepatitis C virus clearance.

@en

P2093

Amalio Telenti

http://www.w3.org/2001/XMLSchema#string

Andri Rauch

http://www.w3.org/2001/XMLSchema#string

Dermot Kelleher

http://www.w3.org/2001/XMLSchema#string

Eleanor Barnes

http://www.w3.org/2001/XMLSchema#string

Karen Fitzmaurice

http://www.w3.org/2001/XMLSchema#string

Margalida Rotger

http://www.w3.org/2001/XMLSchema#string

Patrick Schmid

http://www.w3.org/2001/XMLSchema#string

Raquel Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

IL-28, IL-29 and their class II cytokine receptor IL-28R

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

A map of human genome variation from population-scale sequencing

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Host genetic determinants of spontaneous hepatitis C clearance.

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.

P304

1446-1454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.24263

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Hansjakob Furrer

Enos Bernasconi

Swiss HIV Cohort Study

Huldrych F Günthard

Manuel Battegay

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227721248

http://www.w3.org/2001/XMLSchema#string

P698

21360716

http://www.w3.org/2001/XMLSchema#string

P932

3128709

http://www.w3.org/2001/XMLSchema#string